Ratanapo, S., Srivali, N., Kittanamongkolchai, W., Leeaphorn, N., Ahmed, S., Cheungpasitporn, W., & Chongnarungsin, D. (2013). Metabolic acidosis may increase fibroblast growth factor-23 and cardiovascular mortality in the community. Kidney Int, 84(3), 621. https://doi.org/10.1038/ki.2013.238

Ratanapo, Supawat, Narat Srivali, Wonngarm Kittanamongkolchai, Napat Leeaphorn, Saeed Ahmed, Wisit Cheungpasitporn, and Daych Chongnarungsin. “Metabolic acidosis may increase fibroblast growth factor-23 and cardiovascular mortality in the community.” Kidney Int 84, no. 3 (September 2013): 621. https://doi.org/10.1038/ki.2013.238.

Ratanapo S, Srivali N, Kittanamongkolchai W, Leeaphorn N, Ahmed S, Cheungpasitporn W, et al. Metabolic acidosis may increase fibroblast growth factor-23 and cardiovascular mortality in the community. Kidney Int. 2013 Sep;84(3):621.

Ratanapo, Supawat, et al. “Metabolic acidosis may increase fibroblast growth factor-23 and cardiovascular mortality in the community.” Kidney Int, vol. 84, no. 3, Sept. 2013, p. 621. Pubmed, doi:10.1038/ki.2013.238.

Ratanapo S, Srivali N, Kittanamongkolchai W, Leeaphorn N, Ahmed S, Cheungpasitporn W, Chongnarungsin D. Metabolic acidosis may increase fibroblast growth factor-23 and cardiovascular mortality in the community. Kidney Int. 2013 Sep;84(3):621.